Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2000
11/07/2000US6143774 Imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists
11/07/2000US6143770 Mixtures of tocotrienol and nicotinic acid
11/07/2000US6143761 2,3-dihydrofuro [3,2-β]pyridin, preparation and application thereof in therapy
11/07/2000US6143759 Tetrazoles
11/07/2000US6143751 Pyridine derivatives and pharmaceutical compositions containing them
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143747 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143743 Treatment of nervous system disorders
11/07/2000US6143742 Treatment for necrotizing infections
11/07/2000US6143741 Treating or preventing illnesses resulting from damaged endothelial cells such as atherosclerosis, thrombosis, restenosis, vessel spasm by administering hydroxylamine derivative
11/07/2000US6143740 Administering hergulin compound to inhibit cancer cell growth in mammals
11/07/2000US6143733 Drugs for central nervous system diseases such as parkinson's disease, alzheimer's disease, huntington chorea, amyotrophic lateral sclerosis and olivopontocerebellar degeneration, psychiatric diseases such as anxiety conditions, migraine
11/07/2000US6143724 Used for treatment, improvement and prevention of inflammation and diseases accompanying inflamation
11/07/2000US6143719 Bradykinin analogs as selective thrombin inhibitors
11/07/2000US6143309 Mixture with aprotic solvent; cosmetic
11/07/2000US6143295 Low molecular weight protein
11/07/2000US6143290 Tumor regression by adenovirus expression of wild-type p53
11/07/2000US6143161 Process for the preparation of 4-(des-dimethylamino)-tetracyclines
11/07/2000CA2170485C Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them
11/07/2000CA2118102C New derivatives of 1,2,3,4-tetrahydronaphthalene, preparation process thereof and pharmaceutical compositions containing the same
11/07/2000CA2080223C Thiophene sulfonamides useful as carbonic anhydrase inhibitors
11/07/2000CA2024767C Interferon-gamma receptor fragment and its production
11/07/2000CA1341136C Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
11/02/2000WO2000066152A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000WO2000065091A2 Method of identifying ligands for the peroxisome proliferator activated receptor gamma using differential gene expression
11/02/2000WO2000065069A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000WO2000065068A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2
11/02/2000WO2000064931A1 A ligand of the protein 'beacon'
11/02/2000WO2000064930A2 Tribonectins
11/02/2000WO2000064927A1 Cyclic hexapeptides having antibiotic activity
11/02/2000WO2000064911A1 Ligands for metabotropic glutamate receptors
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064897A1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament
11/02/2000WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000WO2000064891A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof
11/02/2000WO2000064887A1 Renin inhibitors
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064874A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000WO2000064873A1 Renin inhibitors
11/02/2000WO2000064872A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK)
11/02/2000WO2000064869A1 Vitamin d analogues and their pharmaceutical use
11/02/2000WO2000064866A1 Diphenylurea derivatives
11/02/2000WO2000064863A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064481A1 Controlled release of growth factors from heparin containing matrices
11/02/2000WO2000064473A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins
11/02/2000WO2000064470A1 A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/02/2000WO2000064467A1 Inhibition of proteasome function induces programmed cell death in endothelial cells
11/02/2000WO2000064455A1 Method of enhancing the efficacy of anti-tumor agents
11/02/2000WO2000064453A1 Intestinal fermentation sulfide deodorizers
11/02/2000WO2000064449A1 Thrombin inhibitors
11/02/2000WO2000064442A1 Novel anticoagulant injectable composition
11/02/2000WO2000064441A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction
11/02/2000WO2000064422A2 Novel treatment of neurotraumatic conditions with raf inhibitor
11/02/2000WO2000064260A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000WO2000042042A3 High affinity inhibitors for target validation and uses thereof
11/02/2000WO2000041726A3 Noninvasive vascular therapy
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040699A3 Astrocytes, their preparation and uses thereof
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000037464A3 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
11/02/2000WO2000037093A8 Bone resorption inhibitors
11/02/2000WO2000028061A9 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
11/02/2000WO2000018917A3 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION
11/02/2000WO2000004926A3 Conjugates for treating inflammatory disorders and associated tissue damage
11/02/2000WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
11/02/2000EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047787A1 Human calcineurin b-like protein
11/02/2000EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta)
11/02/2000EP1047781A1 Il-18 receptors
11/02/2000EP1047772A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047714A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047712A1 Fatty acid synthase mrna binding protein
11/02/2000EP1047711A1 Nucleic acid sequences encoding capsaicin receptors
11/02/2000EP1047709A1 Compounds with growth hormone releasing properties
11/02/2000EP1047701A1 Mitochondrially targeted antioxidants
11/02/2000EP1047699A1 Platelet adp receptor inhibitors
11/02/2000EP1047698A1 Piperazino derivatives as neurokinin antagonists
11/02/2000EP1047697A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/02/2000EP1047694A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
11/02/2000EP1047692A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
11/02/2000EP1047691A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
11/02/2000EP1047690A1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
11/02/2000EP1047688A1 Thiophene nitrone compounds
11/02/2000EP1047686A1 Substituted bicyclic lactones
1 ... 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 ... 1564